|
Mr. Gaynor joins the AtheroGenics senior executive team with over a decade of pharmaceutical industry experience. Prior to joining AtheroGenics, Mr. Gaynor served as Vice President, General Counsel and Secretary for all U.S. subsidiaries of the Belgian pharmaceuticals group, UCB Pharma. In that role, Mr. Gaynor directed a legal department responsible for licensing and collaborations, mergers and acquisitions, healthcare regulatory and corporate compliance matters, and the strategic management of complex litigation. Prior to joining UCB, Mr. Gaynor served as Legal Counsel at Lanier Worldwide, Inc. and was an associate at the Atlanta law firm of Powell, Goldstein, Frazer & Murphy.
Mr. Gaynor received his law degree from Emory University School of Law in Atlanta, Georgia. | 